Publications
Abstract
Precursor dendritic cell subsets in kidney allograft recipients after induction with alemtuzumab (C1H) vs thym
ASHI 31st Annual Meeting, San Diego, CA, October 17, 2006
Carreno M, Ciancio G, Burke GW, Cirocco R, Mathew J, Miller J, Esquenazi V, Gomez C, Salma F, Jin Y
Carreno M, Ciancio G, Burke GW, Cirocco R, Mathew J, Miller J, Esquenazi V, Gomez C, Salma F, Jin Y (2006). Precursor dendritic cell subsets in kidney allograft recipients after induction with alemtuzumab (C1H) vs thym. ASHI 31st Annual Meeting, San Diego, CA, October 17, 2006.
Using automated extract, transform and load (ETL) processes to build an integrated warehouse of clinical and mechanistic results
American Medical Informatics Association Symposium Spring Congress, Phoenix, AZ, May, 2006
Boyce K, Spencer T
Boyce K, Spencer T (2006). Using automated extract, transform and load (ETL) processes to build an integrated warehouse of clinical and mechanistic results. American Medical Informatics Association Symposium Spring Congress, Phoenix, AZ, May, 2006.
Upregulation of FOXP3 in renal transplantation after antibody induction regimens with and without bone marrow or stem cells
World Transplant Congress, Boston, MA, July 22-27, 2006
Cirocco R, Carreno M, Mathew J, Vallone T, Rosen A, Burke GW, Ciancio G, Esquenazi V, Miller J, Kleiner G
Cirocco R, Carreno M, Mathew J, Vallone T, Rosen A, Burke GW, Ciancio G, Esquenazi V, Miller J, Kleiner G (2006). Upregulation of FOXP3 in renal transplantation after antibody induction regimens with and without bone marrow or stem cells. World Transplant Congress, Boston, MA, July 22-27, 2006.
Time-course analysis of a Double-Blind Placebo Controlled Trail of Grass Pollen Immunotherapy: increased cellular IL-10
Collegium Internationale Allergologicum, Malta, May 5-10, 2006
Francis JN, Wilcock LK, Paraskavopoulos G, Till SJ, Durham SR
Francis JN, Wilcock LK, Paraskavopoulos G, Till SJ, Durham SR (2006). Time-course analysis of a Double-Blind Placebo Controlled Trail of Grass Pollen Immunotherapy: increased cellular IL-10 . Collegium Internationale Allergologicum, Malta, May 5-10, 2006.
Indices of tolerance: Interim Report
World Transplant Congress, Boston, MA, July 22-27, 2006 (Abstract #999)
Hernandez-Fuentes MP, Sagoo P, Flavia R, Jimenez E, Perucha E, Le Moine A, Craciun L, Peters B, Braudeau C, Brouard S, Chapman S, Warrens A, Goldman M, Soulillou JP, Janssen U, Wood K, Lechler RI, Sawitszki B, Trzonkowski P, Warnecke G, Libin M, Volk H-D
Hernandez-Fuentes MP, Sagoo P, Flavia R, Jimenez E, Perucha E, Le Moine A, Craciun L, Peters B, Braudeau C, Brouard S, Chapman S, Warrens A, Goldman M, Soulillou JP, Janssen U, Wood K, Lechler RI, Sawitszki B, Trzonkowski P, Warnecke G, Libin M, Volk H-D (2006). Indices of tolerance: Interim Report. (Abstract #999) World Transplant Congress, Boston, MA, July 22-27, 2006.
Successful Induction of Renal Allograft Tolerance in HLA-Mismatched Kidney Transplant Recipients
FASEB Summer Research Conference, Snowmass, CO, June 3-8, 2006
Kawai T, Spitzer T, Tolkoff-Rubin N, Saidman S, Dey B, Goes N, Ko D, Hertl M, Cotter P, Wong W, Colvin R, Sykes M, Cosimi AB, Sachs D, WilliamsW
Kawai T, Spitzer T, Tolkoff-Rubin N, Saidman S, Dey B, Goes N, Ko D, Hertl M, Cotter P, Wong W, Colvin R, Sykes M, Cosimi AB, Sachs D, WilliamsW (2006). Successful Induction of Renal Allograft Tolerance in HLA-Mismatched Kidney Transplant Recipients. FASEB Summer Research Conference, Snowmass, CO, June 3-8, 2006.
Anti-IgE Therapy Inhibits IgE-facilitated Allergen Presentation and Increases the Efficacy of Ragweed Immunotherapy
2006 AAAAI Annual Meeting, Miami, FL, March 3-7, 2006
Klunker S, Francis JN, Casale TB, Durham SR
Klunker S, Francis JN, Casale TB, Durham SR (2006). Anti-IgE Therapy Inhibits IgE-facilitated Allergen Presentation and Increases the Efficacy of Ragweed Immunotherapy. 2006 AAAAI Annual Meeting, Miami, FL, March 3-7, 2006.
Preliminary results of a tolerance trial in renal transplantation
World Transplant Congress, Boston, MA, July 22-27, 2006
Knechtle SJ, Sollinger HW, Jankowska-Gan E, Burlingham WJ, Bloom DJ
Knechtle SJ, Sollinger HW, Jankowska-Gan E, Burlingham WJ, Bloom DJ (2006). Preliminary results of a tolerance trial in renal transplantation. World Transplant Congress, Boston, MA, July 22-27, 2006.
Circulating and graft infiltrating regulatory cells in donor stem cell infused kidney transplant patients treated with alemtuzumab
12th Innovative Therapeutics in Transplantation Meeting, Nantes, France, June 15, 2006
Mathew J, Carreno M, Cirocco R, Rosen A, Vallone T, Garcia-Morales R, Burke GW, Ciancio G, Esquenazi V, Miller J
Mathew J, Carreno M, Cirocco R, Rosen A, Vallone T, Garcia-Morales R, Burke GW, Ciancio G, Esquenazi V, Miller J (2006). Circulating and graft infiltrating regulatory cells in donor stem cell infused kidney transplant patients treated with alemtuzumab. 12th Innovative Therapeutics in Transplantation Meeting, Nantes, France, June 15, 2006.
Tolerogenicity of graft infiltrating lymphocytes in donor stem cell infused kidney transplant recipients treated with ale
ASHI 31st Annual Meeting, San Diego, CA, October 17, 2006
Mathew J, Cirocco R, Rosen A, Vallone T, Gomez C, Blomberg B, Fuller L, Burke GW, Ciancio G, Esquenazi V, Miller J
Mathew J, Cirocco R, Rosen A, Vallone T, Gomez C, Blomberg B, Fuller L, Burke GW, Ciancio G, Esquenazi V, Miller J (2006). Tolerogenicity of graft infiltrating lymphocytes in donor stem cell infused kidney transplant recipients treated with ale. ASHI 31st Annual Meeting, San Diego, CA, October 17, 2006.
Regulatory cells of donor and recipient phenotypes in donor stem cell infused kidney transplant recipients treated with a
World Transplant Congress, Boston, MA, July 22-27, 2006
Mathew J, Vallone T, Carreno M, Garcia-Morales R, Rosen A, Gomez C, Burke GW, Ciancio G, Esquenazi V, Miller J, Blomberg B, Fuller L
Mathew J, Vallone T, Carreno M, Garcia-Morales R, Rosen A, Gomez C, Burke GW, Ciancio G, Esquenazi V, Miller J, Blomberg B, Fuller L (2006). Regulatory cells of donor and recipient phenotypes in donor stem cell infused kidney transplant recipients treated with a. World Transplant Congress, Boston, MA, July 22-27, 2006.
A web-based clinical trials management system: Integration, annotation and delivery of bioinformatics and clinical data w
American Medical Informatics Association Spring Congress, Phoenix, AZ, May, 2006
Parrish D, McCafferty K
Parrish D, McCafferty K (2006). A web-based clinical trials management system: Integration, annotation and delivery of bioinformatics and clinical data w. American Medical Informatics Association Spring Congress, Phoenix, AZ, May, 2006.
Comparison of two methods CPT and Ficoll to isolate mononuclear cells from peripheral blood. Effect on viability and fu
FOCIS Annual Meeting, San Francisco, CA, June 1-5, 2006
Raddassi K, Bourcier K, Estevam J, Gisler T, Hafler DA, Seyfert-Margolis V
Raddassi K, Bourcier K, Estevam J, Gisler T, Hafler DA, Seyfert-Margolis V (2006). Comparison of two methods CPT and Ficoll to isolate mononuclear cells from peripheral blood. Effect on viability and fu. FOCIS Annual Meeting, San Francisco, CA, June 1-5, 2006.
Fingerprinting tolerance in Renal Transplantation
7th Trends in Immunosuppression, Berlin, Germany, February, 2006 (Abstract #A21)
Sagoo P, Hernandez-Fuentes M, Jimenez-Vera E, Rovis F, Hilton R, Warrens A, Lechler RI
Sagoo P, Hernandez-Fuentes M, Jimenez-Vera E, Rovis F, Hilton R, Warrens A, Lechler RI (2006). Fingerprinting tolerance in Renal Transplantation. (Abstract #A21) 7th Trends in Immunosuppression, Berlin, Germany, February, 2006.
Advances in Immune Monitoring in Renal Transplantation
World Transplant Congress, Boston, MA, July 22-27, 2006 (Abstract #1888)
Sagoo P, Hernandez-Fuentes MP, Jimenez E, Perucha E, Warrens A, Lechler RI, Flavia R, Stevenson S, Milton R
Sagoo P, Hernandez-Fuentes MP, Jimenez E, Perucha E, Warrens A, Lechler RI, Flavia R, Stevenson S, Milton R (2006). Advances in Immune Monitoring in Renal Transplantation. (Abstract #1888) World Transplant Congress, Boston, MA, July 22-27, 2006.
Validation of a Functional Assay of IgE-Facilitated CD23-Dependent Allergen Binding to B Cells to Monitor Clinical Effica
2006 AAAAI Annual Meeting, Miami, FL, March 3-7, 2006
Shamji MH, Wilcock LK, Larché M, Francis JN, Durham SR
Shamji MH, Wilcock LK, Larché M, Francis JN, Durham SR (2006). Validation of a Functional Assay of IgE-Facilitated CD23-Dependent Allergen Binding to B Cells to Monitor Clinical Effica. 2006 AAAAI Annual Meeting, Miami, FL, March 3-7, 2006.
Efficacy of Indirect pathway antigen processing and allorecognition
7th Trends in Immunosuppression, Berlin, Germany, February, 2006 (Abstract #918)
Stevenson S, Hernandez-Fuentes M, Lechler RI, Jiang S, Lombardi G, Barber L
Stevenson S, Hernandez-Fuentes M, Lechler RI, Jiang S, Lombardi G, Barber L (2006). Efficacy of Indirect pathway antigen processing and allorecognition. (Abstract #918) 7th Trends in Immunosuppression, Berlin, Germany, February, 2006.
Treatment of MS patients with TCR peptide vaccine
4th International Workshop on T-Cell Vaccination, Galillee, Israel, February, 2006
Vandenbark AA
Vandenbark AA (2006). Treatment of MS patients with TCR peptide vaccine. 4th International Workshop on T-Cell Vaccination, Galillee, Israel, February, 2006.
Induction of IL-10 Occurs Early and Precedes Serum IgG Blocking Activity During a Cluster Regimen of Grass Pollen Immuno
2006 AAAAI Annual Meeting, Miami, FL, March 3-7, 2006
Wilcock LK, Francis JN, Till SJ, Durham SR, Paraskavopoulos G
Wilcock LK, Francis JN, Till SJ, Durham SR, Paraskavopoulos G (2006). Induction of IL-10 Occurs Early and Precedes Serum IgG Blocking Activity During a Cluster Regimen of Grass Pollen Immuno. 2006 AAAAI Annual Meeting, Miami, FL, March 3-7, 2006.
Increased serum inhibitory activity for basophil histamine release corresponds with reductions in early skin responses i
British Society of Allergy and Clinical Immunology, Loughborough, UK, July, 2006
Wilcock LK, Francis JN, Aalberse RC, Till SJ, Durham SR, Paraskevopolous G, Stapel SO
Wilcock LK, Francis JN, Aalberse RC, Till SJ, Durham SR, Paraskevopolous G, Stapel SO (2006). Increased serum inhibitory activity for basophil histamine release corresponds with reductions in early skin responses i. British Society of Allergy and Clinical Immunology, Loughborough, UK, July, 2006.
Towards semantic interoperability in a clinical trials management system
Fifth International Seman-tic Web Conference (ISWC 2006), Athens, GA, Nov 5-9, 2006
Martins SB, Parrish D, Das AK, Shankar R, O’Connor MJ
Martins SB, Parrish D, Das AK, Shankar R, O’Connor MJ (2006). Towards semantic interoperability in a clinical trials management system. Fifth International Seman-tic Web Conference (ISWC 2006), Athens, GA, Nov 5-9, 2006.
A Knowledge-Based System for Managing Clinical Trials
19th IEEE International Symposium on Computer-Based Medical Systems, Salt Lake City, Utah, June 22-23, 2006
Shankar RD, Martins SB, O'Connor MJ, Parrish DB, Das AK
Shankar RD, Martins SB, O'Connor MJ, Parrish DB, Das AK (2006). A Knowledge-Based System for Managing Clinical Trials. 19th IEEE International Symposium on Computer-Based Medical Systems, Salt Lake City, Utah, June 22-23, 2006.
Epoch: an Ontological Framework to Support Clinical Trials Management
International Workshop on Health Information and Knowledge Management (HIKM 2006), Arlington, VA, Nov 11, 2006
Shankar RD, O'Connor MJ, Parrish DB, Martins SB, Das AK
Shankar RD, O'Connor MJ, Parrish DB, Martins SB, Das AK (2006). Epoch: an Ontological Framework to Support Clinical Trials Management. International Workshop on Health Information and Knowledge Management (HIKM 2006), Arlington, VA, Nov 11, 2006.
Comparison of RNA Preparation Methods and Their Effect on Cytokine/Chemokine Gene Expression
2005 Meeting of the Federation of Clinical Immunology Societies, Boston, MA, May 12-16, 2005 (Abstract #Su1.60)
Asare AL, Kolchinsky SA, Wood P, Seyfert-Margolis VL.
Asare AL, Kolchinsky SA, Wood P, Seyfert-Margolis VL. (2005). Comparison of RNA Preparation Methods and Their Effect on Cytokine/Chemokine Gene Expression. (Abstract #Su1.60) 2005 Meeting of the Federation of Clinical Immunology Societies, Boston, MA, May 12-16, 2005.
Precursor dendritic cell subsets in kidney allograft recipients after induction with alemtuzumab (C1H) vs Thymoglobulin
ASHI 31st Annual Meeting, Washington, DC, Oct 17-21, 2005
Carreno MR, Ciancio G, Burke GW, Cirocco R, Mathew J, Jin Y, Miller J, Salman F, Esquenazi V.
Carreno MR, Ciancio G, Burke GW, Cirocco R, Mathew J, Jin Y, Miller J, Salman F, Esquenazi V. (2005). Precursor dendritic cell subsets in kidney allograft recipients after induction with alemtuzumab (C1H) vs Thymoglobulin. ASHI 31st Annual Meeting, Washington, DC, Oct 17-21, 2005.
Careno-T regulatory cells after induction therapy with Campath-1H, vs Thymoglobulin vs Daclizumab in kidney transplant recipien
American Transplant Congress, Seattle, WA, May 21, 2005
Carreno M, Cirocco R, Mathew J, Ciancio G, Burke GW, Miller J, Esquenazi V.
Carreno M, Cirocco R, Mathew J, Ciancio G, Burke GW, Miller J, Esquenazi V. (2005). Careno-T regulatory cells after induction therapy with Campath-1H, vs Thymoglobulin vs Daclizumab in kidney transplant recipien. American Transplant Congress, Seattle, WA, May 21, 2005.
Casale-Omalizumab pretreatment prevents allergic reactions due to rush immunotherapy (RIT)
AAAAI Annual Meeting, San Antonio, TX, March 18-22, 2005 (Abstract #259)
Casale TB, Kline JN, Busse WW, Ballas ZK, Mokhtarani M, Seyfert-Margolis V, Bateman K, Moss MH, Townley RG.
Casale TB, Kline JN, Busse WW, Ballas ZK, Mokhtarani M, Seyfert-Margolis V, Bateman K, Moss MH, Townley RG. (2005). Casale-Omalizumab pretreatment prevents allergic reactions due to rush immunotherapy (RIT). (Abstract #259) AAAAI Annual Meeting, San Antonio, TX, March 18-22, 2005.
Cirocco-Increased production of the regulatory T-cell transcription factor Fox P-3m-RNA and CD4+CD25+ cells in Campath-1H and do
ASHI 31st Annual Meeting, Washington, DC, Oct 17-21, 2005
Cirocco R, Mathew J, Esquenazi V, Miller J., Careno M, Valone T
Cirocco R, Mathew J, Esquenazi V, Miller J., Careno M, Valone T (2005). Cirocco-Increased production of the regulatory T-cell transcription factor Fox P-3m-RNA and CD4+CD25+ cells in Campath-1H and do. ASHI 31st Annual Meeting, Washington, DC, Oct 17-21, 2005.
Collin-NUSE and RLE: Quality assessment of oligonucleotide microarray data to quantify systemic variation
2005 Meeting of the Federation of Clinical Immunology Societies, Boston, MA, May 12-16, 2005 (Abstract #Su2.110)
Asare AL, Kolchinsky SA, Seyfert-Margolis VL., Collin F, Speed TP
Asare AL, Kolchinsky SA, Seyfert-Margolis VL., Collin F, Speed TP (2005). Collin-NUSE and RLE: Quality assessment of oligonucleotide microarray data to quantify systemic variation. (Abstract #Su2.110) 2005 Meeting of the Federation of Clinical Immunology Societies, Boston, MA, May 12-16, 2005.
Garcia-Comparative chimerism levels in cadaver and living related donor whole bone marrow infused kidney recipients vs. a 2X ste
th Basic Science Symposium of the International Transplantation Society, La Baule, France, June 19-23, 2005
Esquenazi V, Kleiner G, Burke GW, Ciancio G, Ricordi C, Garcia-Morales RO, Cirocco RE, Carreno MR, Kenyon NS, Tzakis AG, Shariatmadar S, Miller J.
Esquenazi V, Kleiner G, Burke GW, Ciancio G, Ricordi C, Garcia-Morales RO, Cirocco RE, Carreno MR, Kenyon NS, Tzakis AG, Shariatmadar S, Miller J. (2005). Garcia-Comparative chimerism levels in cadaver and living related donor whole bone marrow infused kidney recipients vs. a 2X ste. th Basic Science Symposium of the International Transplantation Society, La Baule, France, June 19-23, 2005.
Hernandez0Immune Monitoring in Renal Transplantation
British Society of Immunology, Harrogate, UK, December, 2005
Hernandez-Fuentes MP, Sagoo P, Jimenez E, Rovis F, Stevenson S, Warrens A, Lechler R.
Hernandez-Fuentes MP, Sagoo P, Jimenez E, Rovis F, Stevenson S, Warrens A, Lechler R. (2005). Hernandez0Immune Monitoring in Renal Transplantation. British Society of Immunology, Harrogate, UK, December, 2005.
Kawai
American Transplant Congress, Seattle, WA, May 21, 2005 (Abstract #1535)
Kawai T, Sachs DH, Spitzer T, Tolkoff-Rubin N, Delmonico F, Saidman S, Shaffer J, Williams W, Dey B, McAfee S, Ko D, Hertl M, Goes N, Wong W, Fishman JA, Colvin RB, Sykes M, Cosimi B.
Kawai T, Sachs DH, Spitzer T, Tolkoff-Rubin N, Delmonico F, Saidman S, Shaffer J, Williams W, Dey B, McAfee S, Ko D, Hertl M, Goes N, Wong W, Fishman JA, Colvin RB, Sykes M, Cosimi B. (2005). Kawai. (Abstract #1535) American Transplant Congress, Seattle, WA, May 21, 2005.
Khoury-A Phase I Trial of CTLA4Ig Treatment in MS
57th Annual Meeting of the American Academy of Neurology, Miami Beach, FL, April 9-15, 2005 (Abstract #S46.004)
Khoury SJ, Viglietta V, Hafler D, Bourcier K, Buckle G, Guttmann C, Bikowski M, Rusche J, Landy H, McNally J, Jauregui K.
Khoury SJ, Viglietta V, Hafler D, Bourcier K, Buckle G, Guttmann C, Bikowski M, Rusche J, Landy H, McNally J, Jauregui K. (2005). Khoury-A Phase I Trial of CTLA4Ig Treatment in MS. (Abstract #S46.004) 57th Annual Meeting of the American Academy of Neurology, Miami Beach, FL, April 9-15, 2005.
Kline-Omalizumab Plus Rush Immunotherapy (RIT) Is More Effective Than RIT Alone In Preventing Ragweed-Induced Seasonal Allergic
61st Annual Meeting of the American Academy of Allergy, Asthma and Immunology, San Antonio, TX, March 18-22, 2005 (Abstract #827)
Kline JN, Casale TB, Busse WW, Ballas ZK, Mokhtarani M, Seyfert-Margolis V, Asare A, Bateman K, Moss MH, Bromstead C, Townley RG.
Kline JN, Casale TB, Busse WW, Ballas ZK, Mokhtarani M, Seyfert-Margolis V, Asare A, Bateman K, Moss MH, Bromstead C, Townley RG. (2005). Kline-Omalizumab Plus Rush Immunotherapy (RIT) Is More Effective Than RIT Alone In Preventing Ragweed-Induced Seasonal Allergic . (Abstract #827) 61st Annual Meeting of the American Academy of Allergy, Asthma and Immunology, San Antonio, TX, March 18-22, 2005.
Klunker-Ragweed immunotherapy serum inhibits facilitated allergen presentation
2005 Annual Meeting of the British Society for Allergy & Clinical Immunology, Loughborough, UK, July 18-20, 2005
Klunker S, Francis JN, Durham SR
Klunker S, Francis JN, Durham SR (2005). Klunker-Ragweed immunotherapy serum inhibits facilitated allergen presentation. 2005 Annual Meeting of the British Society for Allergy & Clinical Immunology, Loughborough, UK, July 18-20, 2005.
Liu-Immune monitoring: the effects of hOKT3γ1 (Ala-Ala) in a patient with new onset type 1 diabetes mellitus
Meeting of the Federation of Clinical Immunology Societies, Boston, MA, May 12-16, 2005 (Abstract #Su1.70)
Herold KC, Gitelman SE, Liu WH, Szot G, Earle KE, Masharani U, Bluestone JA.
Herold KC, Gitelman SE, Liu WH, Szot G, Earle KE, Masharani U, Bluestone JA. (2005). Liu-Immune monitoring: the effects of hOKT3γ1 (Ala-Ala) in a patient with new onset type 1 diabetes mellitus. (Abstract #Su1.70) Meeting of the Federation of Clinical Immunology Societies, Boston, MA, May 12-16, 2005.
Mathew-Regulatory cell development in an LRD-kidney transplant recipient treated with alemtuzumab and donor stem cell infusions
ASHI 31st Annual Meeting, Washington, DC, Oct 17-21, 2005
Vallone T, Carreno M, Rosen A, Gomez C, Garcia-Morales R, Blomberg B, Fuller L, Ciancio G, Esquenazi V, Miller J, Mathew JM, Burke G
Vallone T, Carreno M, Rosen A, Gomez C, Garcia-Morales R, Blomberg B, Fuller L, Ciancio G, Esquenazi V, Miller J, Mathew JM, Burke G (2005). Mathew-Regulatory cell development in an LRD-kidney transplant recipient treated with alemtuzumab and donor stem cell infusions . ASHI 31st Annual Meeting, Washington, DC, Oct 17-21, 2005.
Offner-Expression of the Treg cell associated Foxp3 gene is decreased in MS patients and increases following immunization with a
5th Meeting of the European Neurological Society, Vienna, Austria, June 18-22, 2005
Offner H, Huan J, Bartholomew R, Bourdette D, Vandenbark A.
Offner H, Huan J, Bartholomew R, Bourdette D, Vandenbark A. (2005). Offner-Expression of the Treg cell associated Foxp3 gene is decreased in MS patients and increases following immunization with a. 5th Meeting of the European Neurological Society, Vienna, Austria, June 18-22, 2005.
Paraskevop-Grass pollen injection immunotherapy: Time course of suppression of allergen-induced late-phase skin responses
J Allergy Clin Immunology, 115, S266, 2005
Paraskevopoulos G, Jacobson MR, Till SJ, Francis JN, Carr V, Calderon M, Durham SR.
Paraskevopoulos G, Jacobson MR, Till SJ, Francis JN, Carr V, Calderon M, Durham SR. (2005). Paraskevop-Grass pollen injection immunotherapy: Time course of suppression of allergen-induced late-phase skin responses. J Allergy Clin Immunology, 115, S266, 2005.
Raddassi-Effect of freezing/thawing conditions and their optimization for quality control of PBMC viability and functional assay
2005 Meeting of the Federation of Clinical Immunology Societies, Boston, MA, May 12-16, 2005 (Abstract #Su1.106)
Raddassi K, Bourcier K, Estevam J, Hafler DA, Seyfert-Margolis V.
Raddassi K, Bourcier K, Estevam J, Hafler DA, Seyfert-Margolis V. (2005). Raddassi-Effect of freezing/thawing conditions and their optimization for quality control of PBMC viability and functional assay. (Abstract #Su1.106) 2005 Meeting of the Federation of Clinical Immunology Societies, Boston, MA, May 12-16, 2005.
Shamji-Analytical validation of a novel flow cytometric-based Facilitated Allergen Presentation (FAP) assay as a tool for monito
2005 Annual Meeting of the British Society for Allergy & Clinical Immunology, Loughborough, UK, July 18-20, 2005
Larché M, Shamji M, Wilcock L, Durham S, Francis J.
Larché M, Shamji M, Wilcock L, Durham S, Francis J. (2005). Shamji-Analytical validation of a novel flow cytometric-based Facilitated Allergen Presentation (FAP) assay as a tool for monito. 2005 Annual Meeting of the British Society for Allergy & Clinical Immunology, Loughborough, UK, July 18-20, 2005.
Shamkar-A knowledge-driven approach to manage clinical trial protocols in the Immune Tolerance Network
American Medical Informatics Association Symposium, Unknown, October 25, 2005
Shankar R, O'Connor M, Martins S, Tu S, Parrish D, Musen M, Das A.
Shankar R, O'Connor M, Martins S, Tu S, Parrish D, Musen M, Das A. (2005). Shamkar-A knowledge-driven approach to manage clinical trial protocols in the Immune Tolerance Network. American Medical Informatics Association Symposium, Unknown, October 25, 2005.
Vandenbark-Decreased Foxp3 levels in MS patients are normalized by TCR peptide vaccination
19th National Congress of the Polish Neurological Society, Lodz, Poland, Aug 31-Sept 3, 2005
Huan J, Bartholomew R, Offner H, Vandenbark A, Bourdette D.
Huan J, Bartholomew R, Offner H, Vandenbark A, Bourdette D. (2005). Vandenbark-Decreased Foxp3 levels in MS patients are normalized by TCR peptide vaccination. 19th National Congress of the Polish Neurological Society, Lodz, Poland, Aug 31-Sept 3, 2005.
Vandenbark-TCR peptide vaccination in MS induces high levels of IL-10 and restores decreased Foxp3 levels
ECTRIMS/ACTRIMS, Thessaloniki, Greece, Sept 28-Oct 1, 2005
Vandenbark A, Huan J, Bartholomew R, Offner H, Bourdette D.
Vandenbark A, Huan J, Bartholomew R, Offner H, Bourdette D. (2005). Vandenbark-TCR peptide vaccination in MS induces high levels of IL-10 and restores decreased Foxp3 levels. ECTRIMS/ACTRIMS, Thessaloniki, Greece, Sept 28-Oct 1, 2005.
Wilcock0Time-course of serum IgG4 levels and IgG inhibitory activity following withdrawal of grass pollen immunotherapy (IT)
J Allergy Clin Immunology, 115, S265, 2005
Wilcock LK, Wachholz PA, Klunker S, Francis JN, Durham SR, Na D H, Larsen JN
Wilcock LK, Wachholz PA, Klunker S, Francis JN, Durham SR, Na D H, Larsen JN (2005). Wilcock0Time-course of serum IgG4 levels and IgG inhibitory activity following withdrawal of grass pollen immunotherapy (IT). J Allergy Clin Immunology, 115, S265, 2005.
BrooksWorrell-Marked Differences in T Cell Reactivity in Recently Diagnosed Type 1 Diabetes Patients Versus Controls
XXIIth International Congress of Immunology, Montreal, Canada, July 18-23, 2004 (Abstract #2778)
Dosch HM, Seyfert V, Greenbaum CJ, Gitelman SE, Palmer JP, Brooks-Worrell BM, Herold K
Dosch HM, Seyfert V, Greenbaum CJ, Gitelman SE, Palmer JP, Brooks-Worrell BM, Herold K (2004). BrooksWorrell-Marked Differences in T Cell Reactivity in Recently Diagnosed Type 1 Diabetes Patients Versus Controls. (Abstract #2778) XXIIth International Congress of Immunology, Montreal, Canada, July 18-23, 2004.
Casale-Anti-IgE monoclonal antibody administered with immunotherapy
American College of Allergy, Asthma and Immunology (ACAAI), Boston, MA, Nov 4-9, 2004
Casale TB
Casale TB (2004). Casale-Anti-IgE monoclonal antibody administered with immunotherapy. American College of Allergy, Asthma and Immunology (ACAAI), Boston, MA, Nov 4-9, 2004.
Casale-Omalizumab And Immunotherapy
American College of Allergy, Asthma and Immunology (ACAAI), Boston, MA, Nov 4-9, 2004
Casale TB
Casale TB (2004). Casale-Omalizumab And Immunotherapy. American College of Allergy, Asthma and Immunology (ACAAI), Boston, MA, Nov 4-9, 2004.
Eisenbarth-Autoantibodies in type 1 diabetes and neurological disorders.
XXIIth International Congress of Immunology, Montreal, Canada, July 18-23, 2004
Eisenbarthh GS
Eisenbarthh GS (2004). Eisenbarth-Autoantibodies in type 1 diabetes and neurological disorders.. XXIIth International Congress of Immunology, Montreal, Canada, July 18-23, 2004.
Fudaba-Alloresponses in tolerant recipients of combined kidney/bone marrow transplantation with non-myeloablative conditioning
International Congress of Transplantation, Vienna, Austria, Sept 5-10, 2004 (Abstract #P931)
Fudaba Y, Shaffer JM, Kraus A, Cosimi AB, Delmonico FL, Dey B, Kawai T, McAfee S, Preffer F, Tolkoff-Rubin N, Sachs DH, Saidman Sl, Spitzer TR, Sykes M
Fudaba Y, Shaffer JM, Kraus A, Cosimi AB, Delmonico FL, Dey B, Kawai T, McAfee S, Preffer F, Tolkoff-Rubin N, Sachs DH, Saidman Sl, Spitzer TR, Sykes M (2004). Fudaba-Alloresponses in tolerant recipients of combined kidney/bone marrow transplantation with non-myeloablative conditioning. (Abstract #P931) International Congress of Transplantation, Vienna, Austria, Sept 5-10, 2004.